Follow

Submissions from 2019

PDF

Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma, N. E. Berlow, R. Rikhi, M. Geltzeiler, J. Abraham, M. N. Svalina, L. E. Davis, E. Wise, M. Mancini, R. G. Maki, C. Keller, and +19 additional authors

Link

Clinical and molecular characterization of patients with acute myeloid leukemia and sole trisomies of chromosomes 4, 8, 11, 13 or 21, B. Bhatnagar, A. K. Eisfeld, J. Kohlschmidt, K. Mrózek, D. Nicolet, D. Papaioannou, C. J. Walker, S. Orwick, J. E. Kolitz, C. D. Bloomfield, and +5 additional authors

PDF

Eribulin versus dacarbazine in patients with leiomyosarcoma: subgroup analysis from a phase 3, open-label, randomised study, J. Blay, P. Schoffski, S. Bauer, A. Krarup-Hansen, C. Benson, D. R. D'Adamo, Y. Jia, and R. G. Maki

Link

Expression of lymphocyte immunoregulatory biomarkers in bone and soft-tissue sarcomas, A. R. Dancsok, N. Setsu, D. Gao, J. Y. Blay, D. Thomas, R. G. Maki, T. O. Nielsen, and E. G. Demicco

PDF

Older-Patient-Specific Cancer Trials: A Pooled Analysis of 2,277 Patients (A151715)., D. Dao, T. Zemla, A. Jatoi, R. A. Freedman, A. Hurria, H. Muss, H. J. Cohen, M. Citron, D. Budman, J. G. Le-Rademacher, and +6 additional authors

Link

Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma, L. E. Davis, V. Bolejack, C. W. Ryan, K. N. Ganjoo, E. T. Loggers, S. Chawla, M. Agulnik, M. B. Livingston, D. Reed, R. G. Maki, and +7 additional authors

Link

A retrospective analysis of tumor lysis syndrome management in a quaternary care hospital., S. Eng, C. Lee, S. Ahn, and A. Sharma

Link

Mechanism for IL-15-Driven B Cell Chronic Lymphocytic Leukemia Cycling: Roles for AKT and STAT5 in Modulating Cyclin D2 and DNA Damage Response Proteins, R. Gupta, W. Li, X. J. Yan, J. Barrientos, J. E. Kolitz, S. L. Allen, K. Rai, N. Chiorazzi, and P. K. Mongini

PDF

A phase 1 and randomized controlled phase 2 trial of the safety and efficacy of the combination of gemcitabine and docetaxel with ontuxizumab (MORAb-004) in metastatic soft-tissue sarcomas, R. L. Jones, S. P. Chawla, S. Attia, P. Schoffski, H. Gelderblom, B. Chmielowski, A. Le Cesne, B. A. Van Tine, J. C. Trent, R. G. Maki, and +7 additional authors

Link

Safety and efficacy of trabectedin when administered in the inpatient versus outpatient setting: Clinical considerations for outpatient administration of trabectedin, R. L. Jones, R. G. Maki, S. R. Patel, G. Wang, T. A. McGowan, W. S. Shalaby, R. E. Knoblauch, M. von Mehren, and G. D. Demetri

PDF

Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours, R. L. Jones, M. J. Ratain, P. J. O'Dwyer, L. L. Siu, J. Jassem, J. Medioni, M. DeJonge, C. Rudin, R. Maki, G. Schwartz, and +20 additional authors

PDF

An Atypical Presentation of Lichen Planus-Like Reaction from Pembrolizumab., M. Lee and N. Seetharamu

Link

Novel HMGA2-YAP1 fusion gene in aggressive angiomyxoma, M. Y. Lee, B. Da Silva, D. C. Ramirez, and R. G. Maki

PDF

An IRAK1-PIN1 signalling axis drives intrinsic tumour resistance to radiation therapy, P. H. Liu, R. B. Shah, Y. Li, A. Arora, P. M. Ung, R. Raman, A. Gorbatenko, S. Kozono, R. G. Maki, S. Sidi, and +13 additional authors

PDF

Radiation recall pneumonitis in the setting of immunotherapy and radiation: A focused review, K. McGovern, M. Ghaly, M. Esposito, K. Barnaby, and N. Seetharamu

Link

Impact of Tyrosine Kinase Inhibitor Starting Dose on Outcomes in Patients With Non-Small Cell Lung Cancer, E. Miao, N. Seetharamu, K. Sullivan, S. Eng, and C. S. Lee

PDF

Complex karyotype in de novo acute myeloid leukemia: typical and atypical subtypes differ molecularly and clinically, K. Mrózek, A. K. Eisfeld, J. Kohlschmidt, A. J. Carroll, C. J. Walker, D. Nicolet, J. S. Blachly, M. Bill, J. E. Kolitz, C. D. Bloomfield, and +7 additional authors

Link

An unusual case of Kaposi sarcoma masquerading as cystitis in a kidney transplant recipient, V. Nair, F. Sheikh, D. Hirschwerk, A. Fahmy, M. Bhaskaran, E. Grodstein, A. Winnick, R. Maki, L. Teperman, and E. Molmenti

Link

Prognostic and biologic relevance of clinically applicable long noncoding RNA profiling in older patients with cytogenetically normal acute myeloid leukemia, D. Papaioannou, D. Nicolet, H. G. Ozer, K. Mrozek, S. Volinia, P. Fadda, A. J. Carroll, J. Kohlschmidt, J. E. Kolitz, C. D. Bloomfield, and +4 additional authors

PDF

Overall survival and histology-specific subgroup analyses from a phase 3, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma, S. Patel, M. von Mehren, D. R. Reed, P. Kaiser, J. Charlson, C. W. Ryan, D. Rushing, M. Livingston, R. G. Maki, G. D. Demetri, and +10 additional authors

PDF

Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors, M. A. Pulsipher, B. R. Logan, D. M. Kiefer, P. Chitphakdithai, M. L. Riches, D. Rizzo, P. Anderlini, R. Bayer, I. Sahdev, B. E. Shaw, and +51 additional authors

PDF

Excellent Response to Nivolumab and Ipilimumab in Metastatic Gastroesophageal Junction Squamous Carcinoma., N. Sadagopan and C. Devoe

Link

Acute kidney injury in hematopoietic stem cell transplantation, R. Wanchoo, B. R. Stotter, R. L. Bayer, and K. D. Jhaveri

Submissions from 2018

Link

Characterizing the kinetics of lymphocytosis in patients with chronic lymphocytic leukemia treated with single-agent ibrutinib, J. C. Barrientos, J. A. Burger, J. C. Byrd, P. Hillmen, C. Zhou, J. Ninomoto, D. F. James, and T. J. Kipps

PDF

Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLL, J. R. Brown, P. Hillmen, S. O'Brien, J. C. Barrientos, N. M. Reddy, S. E. Coutre, C. S. Tam, S. P. Mulligan, U. Jaeger, J. C. Byrd, and +20 additional authors

Link

A Method to Summarize Toxicity in Cancer Randomized Clinical Trials., M. Carbini, M. Suárez-Fariñas, and R. G. Maki

Link

A Phase II Trial of Sorafenib and Dacarbazine for Leiomyosarcoma, Synovial Sarcoma, and Malignant Peripheral Nerve Sheath Tumors, D. R. D'Adamo, M. A. Dickson, M. L. Keohan, R. D. Carvajal, M. L. Hensley, C. M. Hirst, M. O. Ezeoke, L. Ahn, R. G. Maki, W. D. Tap, and +4 additional authors

Link

TERT promoter mutations in solitary fibrous tumour, E. G. Demicco, K. Wani, D. Ingram, M. Wagner, R. G. Maki, A. Rizzo, A. Meeker, A. J. Lazar, and W. L. Wang

PDF

Mutation patterns identify adult patients with de novo acute myeloid leukemia aged 60 years or older who respond favorably to standard chemotherapy: An analysis of Alliance studies, A. K. Eisfeld, J. Kohlschmidt, K. Mrózek, J. S. Blachly, C. J. Walker, D. Nicolet, S. Orwick, S. E. Maharry, J. E. Kolitz, C. D. Bloomfield, and +6 additional authors

PDF

NF1 mutations are recurrent in adult acute myeloid leukemia and confer poor outcome, A. K. Eisfeld, J. Kohlschmidt, K. Mrózek, A. Mims, C. J. Walker, J. S. Blachly, D. Nicolet, S. Orwick, J. E. Kolitz, C. D. Bloomfield, and +7 additional authors

Link

Mechanistic Insights into CpG DNA and IL-15 Synergy in Promoting B Cell Chronic Lymphocytic Leukemia Clonal Expansion, R. Gupta, X. J. Yan, J. Barrientos, J. E. Kolitz, S. L. Allen, K. Rai, N. Chiorazzi, and P. K. Mongini

Link

Massive liver metastasis from colon adenocarcinoma causing cardiac tamponade, A. N. Halthore, A. Levy, T. Philip, and S. Teckie

Link

Clinical cancer advances 2018: Annual report on progress against cancer from the American Society of Clinical Oncology, J. Heymach, L. Krilov, A. Alberg, N. Baxter, S. M. Chang, R. Corcoran, W. Dale, A. DeMichele, R. G. Maki, H. Burstein, and +12 additional authors

Link

Rasburicase-induced methemoglobinemia: The eyes do not see what the mind does not know, U. Ibrahim, A. Saqib, F. Mohammad, J. P. Atallah, and M. Odaimi

Link

Efficacy and tolerability of trabectedin in elderly patients with sarcoma: Subgroup analysis from a phase III, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma, R. L. Jones, G. D. Demetri, S. M. Schuetze, M. Milhem, A. Elias, B. A. Van Tine, J. Hamm, S. McCarthy, R. G. Maki, M. Von Mehren, and +5 additional authors

Link

Pathologic Angiogenesis of Malignant Vascular Sarcomas: Implications for Treatment, J. A. Khan, R. G. Maki, and V. Ravi

PDF

Cpx-351 (cytarabine and daunorubicin) liposome for injection versus conventional cytarabine plus daunorubicin in older patients with newly diagnosed secondary acute myeloid leukemia, J. E. Lancet, G. L. Uy, J. E. Cortes, L. F. Newell, T. L. Lin, E. K. Ritchie, R. K. Stuart, S. A. Strickland, J. E. Kolitz, B. C. Medeiros, and +11 additional authors

Link

Paraneoplastic Syndrome Secondary to Treatment Emergent Neuroendocrine Tumor in Metastatic Castration-resistant Prostate Cancer: A Unique Case, N. Murphy, J. Shen, A. Shih, A. Liew, H. Khalili, O. Yaskiv, K. Katona, A. Lee, and X. H. Zhu

PDF

Discovery and functional implications of a miR-29b-1/miR-29a cluster polymorphism in acute myeloid leukemia, A. Ngankeu, P. Ranganathan, V. Havelange, D. Nicolet, S. Volinia, B. L. Powell, J. E. Kolitz, G. L. Uy, R. M. Stone, R. Garzon, and +4 additional authors

Link

Carcinosarcomas and Related Cancers: Tumors Caught in the Act of Epithelial-Mesenchymal Transition, A. Pang, M. Carbini, A. L. Moreira, and R. G. Maki

PDF

Bi-specific and tri-specific antibodies- the next big thing in solid tumor therapeutics, K. Runcie, D. R. Budman, V. John, and N. Seetharamu

PDF

Merkel cell carcinoma masquerading as cellulitis: A case report and review of the literature, F. Safa, M. Pant, C. Weerasinghe, R. Felix, and T. Terjanian

PDF

Chylothorax in Patients with Chronic Lymphocytic Leukemia: A Case Series., D. Sammartino, S. Khanijo, S. Koenig, J. F. Katsetos, A. Tufano, K. R. Rai, and J. C. Barrientos

PDF

Hybrid capture–based genomic profiling of circulating tumor DNA from patients with advanced cancers of the gastrointestinal tract or anus, A. B. Schrock, D. Pavlick, S. J. Klempner, J. H. Chung, B. Forcier, A. Welsh, L. Young, B. Leyland-Jones, C. Devoe, V. A. Miller, and +9 additional authors

Link

Sarcoma: The Merging of Science and Clinical Care, G. K. Schwartz and R. G. Maki

PDF

Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma, S. Stacchiotti, O. Mir, A. Le Cesne, B. Vincenzi, A. Fedenko, R. G. Maki, N. Somaiah, S. Patel, M. Brahmi, A. Kawai, and +13 additional authors

Link

Extraocular Muscle Metastasis from Esophageal Carcinoma: an Atypical and Rare Presentation, N. Thumallapally, S. El-Bitar, F. Mohammad, and J. P. Atallah

Link

Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer, H. Tiriac, P. Belleau, D. D. Engle, D. Plenker, A. Deschenes, D. V. Sejpal, J. D. Sullivan, J. M. Crawford, C. Devoe, D. A. Tuveson, and +60 additional authors

PDF

Genome-wide association study identifies an acute myeloid leukemia susceptibility locus near BICRA, C. J. Walker, C. C. Oakes, L. K. Genutis, B. Giacopelli, S. Liyanarachchi, D. Nicolet, A. K. Eisfeld, M. Scholz, J. E. Kolitz, C. D. Bloomfield, and +12 additional authors

PDF

Renal involvement in chronic lymphocytic leukemia., R. Wanchoo, C. Bernabe Ramirez, J. Barrientos, and K. D. Jhaveri

PDF

Oral curcumin for radiation dermatitis: a URCC NCORP study of 686 breast cancer patients, J. R. Wolf, C. E. Heckler, J. J. Guido, A. R. Peoples, J. S. Gewandter, M. Ling, V. P. Vinciguerra, T. Anderson, L. Evans, G. R. Morrow, and +2 additional authors

Submissions from 2016

Link

A case of acute kidney injury from crystal nephropathy secondary to pomalidomide and levofloxacin use, P. Baird, S. Leung, H. Hoang, O. Babalola, C. E. Devoe, R. Wanchoo, and K. D. Jhaveri

PDF

Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia, J. C. Byrd, B. Harrington, S. O'Brien, J. A. Jones, A. Schuh, S. Devereux, J. Chaves, W. G. Wierda, J. C. Barrientos, R. R. Furman, and +20 additional authors

PDF

Relationship between obesity and clinical outcome in adults with acute myeloid leukemia: A pooled analysis from four CALGB (alliance) clinical trials, J. J. Castillo, F. Mulkey, S. Geyer, J. E. Kolitz, W. Blum, B. L. Powell, S. L. George, R. A. Larson, and R. M. Stone

PDF

BTK inhibition results in impaired CXCR4 chemokine receptor surface expression, signaling and function in chronic lymphocytic leukemia, S. S. Chen, B. Y. Chang, S. Chang, T. Tong, S. Ham, B. Sherry, J. A. Burger, K. R. Rai, and N. Chiorazzi

PDF

Cytoplasmic myosin-exposed apoptotic cells appear with caspase-3 activation and enhance CLL cell viability, X. Cui, L. Zhang, A. R. Magli, R. Catera, X. J. Yan, D. O. Griffin, T. L. Rothstein, J. Barrientos, J. E. Kolitz, S. L. Allen, K. R. Rai, N. Chiorazzi, and C. C. Chu

PDF

Pomalidomide reverses gamma-globin silencing through the transcriptional reprogramming of adult hematopoietic progenitors, B. M. Dulmovits, A. O. Appiah-Kubi, J. Papoin, M. He, Y. Al-Abed, S. Didier, M. Gould, S. Husain-Krautter, S. A. Singh, A. Vlachos, S. L. Allen, J. M. Lipton, J. M. Liu, L. Blanc, and +7 additional authors

PDF

Sotatercept (ACE-011) for the treatment of chemotherapy-induced anemia in patients with metastatic breast cancer or advanced or metastatic solid tumors treated with platinum-based chemotherapeutic regimens: results from two phase 2 studies, H. Raftopoulos, A. Laadem, P. J. Hesketh, J. Goldschmidt, N. Gabrail, C. Osborne, M. Ali, M. L. Sherman, D. Wang, J. Crawford, and +3 additional authors

Link

Chronic lymphocytic leukemia (CLL) - Then and Now, K. R. Rai and P. Jain

PDF

A Phase II randomized trial comparing standard and low dose rituximab combined with alemtuzumab as initial treatment of progressive chronic lymphocytic leukemia in older patients: A Trial of the ECOG-ACRIN Cancer Research Group (E1908), C. S. Zent, X. V. Wang, R. P. Ketterling, C. A. Hanson, E. N. Libby, J. C. Barrientos, T. G. Call, J. E. Chang, J. J. Liu, M. S. Tallman, and +5 additional authors

Submissions from 2015

Link

Adoption of a Uniform Start Date for Internal Medicine Fellowships and Other Advanced Training: An AAIM White Paper, J. C. Barrett, R. Alweis, M. Frank, A. O'Connor, J. F. McConville, N. D. Adams, L. Arfons, S. Bernard, T. Bradley, E. A. Muchmore, and +13 additional authors

PDF

Management of Chronic Lymphocytic Leukemia in the Elderly, J. C. Barrientos

PDF

Romidepsin in peripheral and cutaneous T-cell lymphoma: mechanistic implications from clinical and correlative data, S. E. Bates, R. Eisch, A. Ling, D. Rosing, M. Turner, S. Pittaluga, H. M. Prince, M. H. Kirschbaum, S. L. Allen, R. L. Piekarz, and +15 additional authors

PDF

Clinical features, and gene- and microRNA-expression patterns in adult acute leukemia patients with t(11;19)(q23;p13.1) and t(11;19)(q23;p13.3), B. Bhatnagar, J. S. Blachly, J. Kohlschmidt, A. K. Eisfeld, S. Volinia, D. Nicolet, A. J. Carroll, A. M. Block, J. E. Kolitz, C. D. Bloomfield, and +3 additional authors

PDF

The Bruton tyrosine kinase inhibitor ibrutinib with chemoimmunotherapy in patients with chronic lymphocytic leukemia, J. R. Brown, J. C. Barrientos, P. M. Barr, I. W. Flinn, J. A. Burger, A. Tran, F. Clow, D. F. James, K. Rai, S. O'Brien, and +2 additional authors

PDF

Phase II, Multicenter, Randomized Trial of CPX-351 (cytarabine: daunorubicin) Liposome Injection Versus Intensive Salvage Therapy in Adults With First Relapse AML, J. E. Cortes, S. L. Goldberg, E. J. Feldman, D. A. Rizzeri, D. E. Hogge, M. Larson, A. Pigneux, C. Recher, G. Schiller, J. E. Kolitz, and +3 additional authors

PDF

Management of adverse events associated with idelalisib treatment: expert panel opinion, S. E. Coutre, J. C. Barrientos, J. R. Brown, S. de Vos, R. R. Furman, M. J. Keating, D. Li, S. M. O'Brien, J. M. Pagel, A. D. Zelenetz, and +3 additional authors

Link

Prospective contouring rounds: A novel, high-impact tool for optimizing quality assurance, B. W. Cox, A. Kapur, A. Sharma, L. Lee, B. Bloom, R. Sharma, G. Goode, and L. Potters

Link

Acquired factor V inhibitor after exposure to topical human thrombin related to an otorhinolaryngological procedure, K. Donohoe and R. Levine

Link

PEG-asparaginase induced severe hypertriglyceridemia, R. J. Galindo, J. Yoon, C. Devoe, and A. K. Myers

Link

B-cell precursor acute lymphoblastic leukemia with isolated t(14;19)(q32;q13) abnormality involving the CEBPG gene, N. Haghi, J. Brody, N. Mahmood, D. Gheewala, S. L. Allen, C. Sreekantaiah, and X. Zhang

PDF

Non-Small-Cell Lung Cancer Clinicopathologic Features and Survival Outcomes in Asian Pacific Islanders Residing in the United States: A SEER Analysis, M. S. Hamid, R. Shameem, K. Gafoor, J. George, B. Mina, and K. Sullivan

Link

Subcutaneous injections of low doses of humanized anti-CD20 veltuzumab: A phase I study in chronic lymphocytic leukemia, M. E. Kalaycio, O. G. Negrea, S. L. Allen, K. R. Rai, R. M. Abbasi, H. Horne, W. A. Wegener, and D. M. Goldenberg

PDF

Feasibility and Cardiac Safety of Trastuzumab Emtansine After Anthracycline-Based Chemotherapy As (neo) Adjuvant Therapy for Human Epidermal Growth Factor Receptor 2-Positive Early-Stage Breast Cancer, I. E. Krop, T. M. Suter, C. T. Dang, L. Dirix, G. Romieu, C. Zamagni, M. L. Citron, M. Campone, N. Xu, M. Smitt, and L. Gianni

PDF

Integrating targeted drugs with taxanes and platinums: opportunities and challenges, D. Kudlowitz, E. Teplinsky, and F. Muggia

PDF

Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer: CALGB 9741 (Alliance), J. A. Ligibel, C. T. Cirrincione, M. Liu, M. Citron, J. N. Ingle, W. Gradishar, S. Martino, W. Sikov, R. Michaelson, W. T. Barry, and +6 additional authors

PDF

Acute myeloid leukemia ontogeny is defined by distinct somatic mutations, R. C. Lindsley, B. G. Mar, E. Mazzola, P. V. Grauman, S. Shareef, S. L. Allen, A. Pigneux, M. Wetzler, R. K. Stuart, B. L. Ebert, and +9 additional authors

Link

Myelodysplastic syndromes spatial clusters in disease etiology and outcome, B. Liu, S. M. Kerath, M. A. Sekeres, J. P. Fryzek, C. Sreekantaiah, C. R. Mason, J. Kolitz, and E. Taioli

Link

A seven-gene expression panel distinguishing clonal expansions of pre-leukemic and chronic lymphocytic leukemia B cells from normal B lymphocytes, B. A. McCarthy, S. Yancopoulos, X. J. Yan, X. P. Wang, W. Li, M. Lesser, S. Paul, E. Boyle, C. Moreno, R. Catera, B. T. Messmer, J. E. Kolitz, S. L. Allen, K. R. Rai, N. Chiorazzi, and +5 additional authors

PDF

TLR-9 and IL-15 Synergy Promotes the In Vitro Clonal Expansion of Chronic Lymphocytic Leukemia B Cells, P. K. A. Mongini, R. Gupta, E. Boyle, J. Nieto, H. Lee, J. Stein, J. Bandovic, T. Stankovic, J. Barrientos, J. E. Kolitz, S. L. Allen, K. Rai, C. C. Chu, and N. Chiorazzi

PDF

Introduction: moving beyond chemotherapy, F. Muggia and E. Teplinsky

PDF

Calreticulin Mutated Essential Thrombocythemia Presenting as Acute Coronary Syndrome, B. Nazha, G. Garcia, R. Kandov, and M. Odaimi

PDF

Phase II double-blind placebo-controlled randomized study of armodafinil for brain radiation-induced fatigue, B. R. Page, E. G. Shaw, L. Lu, D. Bryant, D. Grisell, G. J. Lesser, D. C. Monitto, M. J. Naughton, S. R. Savona, M. D. Chan, and +3 additional authors

PDF

Rewiring of sIgM-Mediated Intracellular Signaling through the CD180 Toll-like Receptor, N. Porakishvili, K. Vispute, A. J. Steele, N. Rajakaruna, N. Kulikova, T. Tsertsvadze, R. N. Damle, K. R. Rai, N. Chiorazzi, P. M. Lydyard, and +2 additional authors

Slow-release granisetron (APF530) versus palonosetron for chemotherapy-induced nausea/vomiting: analysis by American Society of Clinical Oncology emetogenicity criteria, H. Raftopoulos, R. Boccia, W. Cooper, E. O'Boyle, and R. J. Gralla

PDF

Therapeutic potential of new B cell-targeted agents in the treatment of elderly and unfit patients with chronic lymphocytic leukemia, K. R. Rai

PDF

Tamibarotene in patients with acute promyelocytic leukaemia relapsing after treatment with all-trans retinoic acid and arsenic trioxide, D. Sanford, F. Lo-Coco, M. A. Sanz, E. Di Bona, S. Coutre, J. K. Altman, M. Wetzler, S. L. Allen, F. Ravandi, H. Kantarjian, and J. E. Cortes

Link

Ex vivo Efficacy of Anti-Cancer Drug PNC-27 in the Treatment of Patient-Derived Epithelial Ovarian Cancer, E. Sarafraz-Yazdi, C. Gorelick, A. R. Wagreich, G. Salame, M. Angert, C. H. Gartman, V. Gupta, W. B. Bowne, Y. C. Lee, J. Michl, and +2 additional authors

PDF

Successful pregnancy outcome in paroxysmal nocturnal hemoglobinuria (PNH) following escalated eculizumab dosing to control breakthrough hemolysis, R. Sharma, A. Keyzner, J. Liu, T. Bradley, and S. L. Allen

PDF

Identification and characterization of distinct IL-17F expression patterns and signaling pathways in chronic lymphocytic leukemia and normal B lymphocytes, B. Sherry, P. Jain, P. Y. Chiu, L. Leung, S. L. Allen, J. E. Kolitz, K. R. Rai, J. Barrientos, S. Liang, R. Hawtin, and N. Chiorazzi

Link

Phase III Open-Label Randomized Study of Cytarabine in Combination With Amonafide L-Malate or Daunorubicin As Induction Therapy for Patients With Secondary Acute Myeloid Leukemia, R. M. Stone, E. Mazzola, D. Neuberg, S. L. Allen, A. Pigneux, R. K. Stuart, M. Wetzler, D. Rizzieri, H. P. Erba, B. Powell, and +12 additional authors

PDF

Primary extranodal marginal zone lymphoma of the endometrium: report of four cases and review of literature, F. C. Tahmasebi, S. Roy, J. E. Kolitz, F. Sen, J. Laser, and X. Zhang

PDF

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs, A. Tefferi, K. Rai, A. I. Schafer, C. Schiffer, M. A. Sekeres, L. L. Siu, F. M. Stewart, M. Thompson, J. M. Vose, P. H. Wiernik, and +109 additional authors

Link

Systemic Therapy for HER2-Positive Central Nervous System Disease: Where We Are and Where Do We Go From Here?, E. Teplinsky and F. J. Esteva

PDF

EGFR and HER2: is there a role in ovarian cancer?, E. Teplinsky and F. Muggia

PDF

Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia, E. Tiacci, J. H. Park, L. De Carolis, S. S. Chung, A. Broccoli, S. Scott, F. Zaja, S. Devlin, K. R. Rai, M. S. Tallman, and +31 additional authors

PDF

Augmenting NF-kappaB in poor-risk CLL: A general paradigm for other cancers?, D. Tuveson and K. R. Rai

Link

Bleomycin-induced flagellate erythema in a patient with Hodgkin's lymphoma - A case report and review of literature, A. Vennepureddy, M. N. Siddique, M. Odaimi, and T. Terjanian

PDF

Long-term follow-up of MCL patients treated with single-agent ibrutinib: updated safety and efficacy results, M. L. Wang, K. A. Blum, P. Martin, A. Goy, R. Auer, B. S. Kahl, W. Jurczak, R. H. Advani, J. C. Barrientos, S. Rule, and +14 additional authors

Link

Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma, W. H. Wilson, R. M. Young, R. Schmitz, Y. D. Yang, S. Pittaluga, G. Wright, C. J. Lih, P. M. Williams, J. C. Barrientos, L. M. Staudt, and +20 additional authors